New discoveries are showing how genetic variations can affect our health, from disease risks to how we respond to medicines. Understanding the genetics of animals, plants, and microbes helps us see ...

What Happened? A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as ...

The global forensic genomics market size was valued at US$ 0.5 Bn in 2024 and is projected to reach US$ 2.4 Bn by 2035, ...

Google hasn’t just topped benchmarks with its Gemini 3 model, but it’s also won the admiration of its rivals. CEOs of rival ...

Opus Genetics, Inc. (IRD) delivered earnings and revenue surprises of +14.29% and +11.36%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the ...

Genetically engineered breeders that lay only female chicks would eliminate the culling of day-old male chicks.

What we choose to study—whether fine art or finance—is one of the most influential decisions in our lives. It shapes not only ...

Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.

The data set included information on their social media habits—including number of platforms used, total time spent on social ...

Key Insights Given the large stake in the stock by institutions, Fulgent Genetics' stock price might be vulnerable ...

A clandestine startup privately funded by tech billionaires is looking into germline gene editing a human embryo.

Eli Lilly and Company, Novo Nordisk A/S, Relay Therapeutics Inc, Neumora Therapeutics Inc. Read 's Market Analysis on Investing.com ZA.